<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="41933">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01998724</url>
  </required_header>
  <id_info>
    <org_study_id>2012P-000220</org_study_id>
    <secondary_id>R01AT006358</secondary_id>
    <nct_id>NCT01998724</nct_id>
  </id_info>
  <brief_title>Tai Chi After Pulmonary Rehabilitation in Patients With COPD: A Randomized Trial</brief_title>
  <acronym>LEAP</acronym>
  <official_title>Tai Chi After Pulmonary Rehabilitation in Patients With COPD: A Randomized Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Beth Israel Deaconess Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institutes of Health (NIH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Center for Complementary and Alternative Medicine (NCCAM)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Beth Israel Deaconess Medical Center</source>
  <oversight_info>
    <authority>United States: Data and Safety Monitoring Board</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main purpose of this study is to determine the feasibility and effects of a 6-month tai
      chi exercise program as compared to a 6-month group walking program and standard care for
      patients with COPD that have recently completed a pulmonary rehabilitation program.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2012</start_date>
  <completion_date type="Anticipated">September 2017</completion_date>
  <primary_completion_date type="Anticipated">September 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor)</study_design>
  <primary_outcome>
    <measure>Feasibility of tai chi intervention</measure>
    <time_frame>24 weeks</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Willingness to participate, adherence, and safety</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change from baseline - Disease specific quality of life</measure>
    <time_frame>Baseline, 12 weeks, 24 weeks, 1 year</time_frame>
    <safety_issue>No</safety_issue>
    <description>Chronic Respiratory Questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline - Exercise capacity</measure>
    <time_frame>Baseline, 12 weeks, 24 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>Six minute walk distance</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline - Dyspnea</measure>
    <time_frame>Baseline, 12 weeks, 24 weeks, 1 year</time_frame>
    <safety_issue>No</safety_issue>
    <description>University of California, San Diego Shortness of Breath Questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline - Psychosocial well-being</measure>
    <time_frame>Baseline, 12 weeks, 24 weeks, 1 year</time_frame>
    <safety_issue>No</safety_issue>
    <description>Center for Epidemiologic Studies Depression Scale, Perceived Stress Scale, COPD Self-Efficacy Scale, Multidimensional Scale of Perceived Social Support</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes from baseline - Pulmonary function</measure>
    <time_frame>Baseline, 12 weeks, 24 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>Spirometry</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline - Exercise Efficacy</measure>
    <time_frame>Throughout study</time_frame>
    <safety_issue>No</safety_issue>
    <description>Daily exercise activities, step counts taken at baseline, 12 weeks, 24 weeks, 1 year</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Chronic Obstructive Pulmonary Disease (COPD)</condition>
  <arm_group>
    <arm_group_label>Standard Care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>No intervention</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Tai Chi Exercise</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>24 week Tai Chi intervention designed for individuals with COPD</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group Walking Exercise</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>24 week group walking intervention</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Tai Chi</intervention_name>
    <description>24 week tai chi intervention designed for individuals with COPD</description>
    <arm_group_label>Tai Chi Exercise</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Group Walking</intervention_name>
    <description>24 week group walking intervention</description>
    <arm_group_label>Group Walking Exercise</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. COPD defined as FEV1 (Forced exiratory volume in 1 second)/FVC (Forced vital
             capacity) &lt;0.70 or chest CT evidence of emphysema

          2. Age &gt; 40 years

          3. Any severity of COPD as defined by GOLD (Global Obstructive Lung Disease) stages 1,
             2,3, or 4

          4. Completion of standard pulmonary rehabilitation of at least 8 weeks duration within
             24  weeks prior to study entry* *Defined as attending 65% of the program's sessions
             with a minimum of 10 sessions

        Exclusion Criteria:

          1. COPD exacerbation requiring steroids, antibiotics, ED visit or hospitalization within
             the past 2 weeks

          2. Hypoxemia on walk test (O2 sat &lt; 85% on oxygen)

          3. Inability to ambulate due to vascular or other neuromuscular conditions that would
             preclude a walk test

          4. Clinical signs of unstable cardiovascular disease (ie. chest pain on walk test)

          5. Severe cognitive dysfunction (documented Mini-Mental Status Exam â‰¤ 24)

          6. Non-English speaking

          7. Current regular practice of tai chi

          8. History of lung cancer

          9. Unstable/untreated mental health issue that precludes informed consent or otherwise
             affects ability to participate in the intervention
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gloria Yeh, MD, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>BIDMC, Harvard Medical School</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Daniel Litrownik, BA</last_name>
    <phone>617-754-1423</phone>
    <email>dlitrown@bidmc.harvard.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Caroline Chan, BA</last_name>
    <phone>617-754-1458</phone>
    <email>cchan5@caregroup.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Beth Israel Deaconess Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02215</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>VA Healthcare System</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02130</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marilyn Moy, MD</last_name>
      <phone>857-203-5126</phone>
      <email>marilyn.moy@va.gov</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2013</verification_date>
  <lastchanged_date>November 25, 2013</lastchanged_date>
  <firstreceived_date>November 25, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Chronic bronchitis</keyword>
  <keyword>Emphysema</keyword>
  <keyword>Pulmonary</keyword>
  <keyword>COPD</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Respiration Disorders</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
    <mesh_term>Lung Diseases, Obstructive</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
